Conservest Capital Advisors, Inc. Vaneck ETF Tr Vaneck Pharmaceu Transaction History

Conservest Capital Advisors, Inc.

$1 Billion
Q2 2025

A detailed history of Conservest Capital Advisors, Inc. transactions in Vaneck ETF Tr Vaneck Pharmaceu stock. As of the latest transaction made, Conservest Capital Advisors, Inc. holds 5,059 shares of PPH stock, worth $464,416. This represents 0.04% of its overall portfolio holdings.

Number of Shares

5,059

Previous 5,051 0.16%

Holding current value

$464,416

Previous $460,000 3.48%

% of portfolio

0.04%

Previous 0.05%

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 31, 2025	BUY	$80.28 - $91.78 $642 - $734	8 Added 0.16%	5,059 $444,000
Q4 2024 Feb 05, 2025	BUY	$86.03 - $94.92 $1,892 - $2,088	22 Added 0.44%	5,051 $435,000
Q1 2024 May 02, 2024	SELL	$82.63 - $90.89 $38,670 - $42,536	-468 Reduced 8.51%	5,029 $456,000
Q4 2023 Feb 05, 2024	BUY	$74.32 - $81.37 $408,537 - $447,290	5,497 New	5,497 $447,000
Q4 2017 Jan 10, 2018	SELL	N/A	-5,000 Closed	0 $0
Q3 2017 Oct 12, 2017	BUY	N/A	5,000	5,000 $289,000

Others Institutions Holding PPH

# of Institutions

140

Shares Held

7.17M

Call Options Held

37.7K

Put Options Held

471K

View Full List

About VANECK ETF TR VANECK PHARMACEU

Ticker PPH
Sector ETFs
Industry ETFs

More about PPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Conservest Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Conservest Capital Advisors, Inc. with notifications on news.

Account

Conservest Capital Advisors, Inc. Vaneck ETF Tr Vaneck Pharmaceu Transaction History